DK1487261T3 - Fremgangsmåder og sammensætninger til farmakologisk og toksikologisk evaluering af testpræparater - Google Patents

Fremgangsmåder og sammensætninger til farmakologisk og toksikologisk evaluering af testpræparater

Info

Publication number
DK1487261T3
DK1487261T3 DK03744148T DK03744148T DK1487261T3 DK 1487261 T3 DK1487261 T3 DK 1487261T3 DK 03744148 T DK03744148 T DK 03744148T DK 03744148 T DK03744148 T DK 03744148T DK 1487261 T3 DK1487261 T3 DK 1487261T3
Authority
DK
Denmark
Prior art keywords
pharmacological
compositions
methods
test preparations
toxicological evaluation
Prior art date
Application number
DK03744148T
Other languages
Danish (da)
English (en)
Inventor
Howard J Jacobs
Richard J Roman
Steven H Nye
Original Assignee
Mcw Res Found Inc
Physiogenix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcw Res Found Inc, Physiogenix Inc filed Critical Mcw Res Found Inc
Application granted granted Critical
Publication of DK1487261T3 publication Critical patent/DK1487261T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/142—Toxicological screening, e.g. expression profiles which identify toxicity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
DK03744148T 2002-03-05 2003-03-04 Fremgangsmåder og sammensætninger til farmakologisk og toksikologisk evaluering af testpræparater DK1487261T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36189002P 2002-03-05 2002-03-05
PCT/US2003/006421 WO2003075838A2 (fr) 2002-03-05 2003-03-04 Procedes et compositions d'evaluation pharmacologique et toxicologique d'agents d'essai

Publications (1)

Publication Number Publication Date
DK1487261T3 true DK1487261T3 (da) 2008-11-24

Family

ID=27805091

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03744148T DK1487261T3 (da) 2002-03-05 2003-03-04 Fremgangsmåder og sammensætninger til farmakologisk og toksikologisk evaluering af testpræparater

Country Status (8)

Country Link
US (1) US20030237103A1 (fr)
EP (1) EP1487261B1 (fr)
JP (1) JP2005520503A (fr)
AT (1) ATE406093T1 (fr)
AU (1) AU2003216489A1 (fr)
DE (1) DE60323214D1 (fr)
DK (1) DK1487261T3 (fr)
WO (1) WO2003075838A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003267245C1 (en) * 2002-09-20 2008-05-29 Promega Corporation Luminescence-based methods and probes for measuring cytochrome P450 activity
EP2272973B1 (fr) * 2005-05-31 2015-05-27 Promega Corporation Composés luminogènes et fluorogènes et procédés pour la détection de molécules ou de conditions
US8612176B2 (en) * 2007-01-26 2013-12-17 Auburn University Nominal population metric: clustering of nominal application attributes
US7844609B2 (en) * 2007-03-16 2010-11-30 Expanse Networks, Inc. Attribute combination discovery
US8288559B2 (en) * 2008-08-18 2012-10-16 Promega Corporation Luminogenic compounds and methods to detect cytochrome P450 3A enzymes
US8463554B2 (en) 2008-12-31 2013-06-11 23Andme, Inc. Finding relatives in a database
WO2015116867A1 (fr) 2014-01-29 2015-08-06 Promega Corporation Sondes masquées par quinone utilisées comme réactifs de marquage pour mesurer l'absorption cellulaire

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992007095A1 (fr) * 1990-10-15 1992-04-30 Stratagene Procede de reaction en chaine de polymerase arbitrairement amorcee destine a produire une empreinte genetique de genomes
US5580728A (en) * 1994-06-17 1996-12-03 Perlin; Mark W. Method and system for genotyping
CA2318880C (fr) * 1998-02-04 2010-07-27 Applied Biosystems, Llc Determination d'un genotype d'un produit d'amplification sur des sites alleliques multiples
US6465551B1 (en) * 2001-03-24 2002-10-15 Milliken & Company Bicyclo[2.2.1]heptane dicarboxylate salts as polyolefin nucleators
US6534574B1 (en) * 2001-03-24 2003-03-18 Milliken & Company Highly nucleated thermoplastic articles

Also Published As

Publication number Publication date
ATE406093T1 (de) 2008-09-15
EP1487261A4 (fr) 2005-04-13
DE60323214D1 (de) 2008-10-09
AU2003216489A1 (en) 2003-09-22
JP2005520503A (ja) 2005-07-14
US20030237103A1 (en) 2003-12-25
AU2003216489A8 (en) 2003-09-22
EP1487261B1 (fr) 2008-08-27
WO2003075838A3 (fr) 2003-12-04
WO2003075838A2 (fr) 2003-09-18
EP1487261A2 (fr) 2004-12-22

Similar Documents

Publication Publication Date Title
EP1709195A4 (fr) Formulations de transfection cellulaire de petits arn interferents, compositions correspondantes et procedes de production et d'utilisation
CY1109579T1 (el) Μιμητοσωματα του πυρηνα αρθρωσης μιμητικα της ανθρωπινης ερο, συνθεσεις, μεθοδοι και χρησεις
WO2004099447A3 (fr) Mais tc1507 et procedes de detection de celui-ci
EP1581641A4 (fr) Compositions, variants d'epissage et methodes concernant des genes et des proteines specifiques des ovaires
NO20025489L (no) Stabiliserte tetrasolium-fenasin-reagens-sammensetninger og fremgangsmåterfor deres anvendelse
IS6316A (is) Aðferð til erfðafræðilegra greininga
IL177495A0 (en) Methods of isolating and identifying cells using signaling probes
DK1626979T3 (da) Genetisk modificeret gærart og fremgangsmåder til fermentering, hvor den genetisk modificerede gær anvendes
TW200630033A (en) Corn event DAS-59122-7 and methods for detection thereof
DK1546174T3 (da) Fremgangsmåder og sammensætninger til RNA-interferens
NO20044807L (no) Heratitt C virus inhibitorer
DK1167531T3 (da) Sammensætninger og fremgangsmåder til påvisning af majstransformant PV-ZMGT32 (NK603)
NO20013393D0 (no) Brönnsementeringsfremgangsmåter og sammensetninger
WO2003029264A3 (fr) Analogues de 2-propynyle adenosine presentant une activite agoniste de a2a et compositions en contenant
DE60220250D1 (de) Produktion eines monoklonaken antikörpers durch eine transgene vogelspezies
DE10393257D2 (de) Tubulysin-Biosynthese-Gene
EP1628993A4 (fr) Procedes et compositions d'interference d'arn
AU2003216489A8 (en) Methods and compositions for pharmacological and toxicological evaluation of test agents
NO20031997L (no) CRF-reseptor-antagonist og metoder relatert dertil
WO2003076897A3 (fr) Analyse multiplexee des reponses cellulaires au moyen de genes rapporteurs endogenes
WO2001070778A3 (fr) Compositions de promoteurs de la proteine riche en glycine de mais et procedes d'utilisation associes
DK1282639T3 (da) Polyamidnucleinsyrederivater, midler og fremgangsmåder til fremstilling heraf
EP1677100A4 (fr) Cellule d'equilibre permettant d'etudier le comportement de phase d'hydrocarbures
EP1198586A4 (fr) Selection in vivo bibliotheque contre bibliotheque d'interactions proteine-proteine optimisees
ATE384047T1 (de) Piperidin-derivate zur verwendung als 2,3- oxidosqualen-lanosterol zyklase inhibitoren